Gardin, A., Ufer, M., Legangneux, E., Rossato, G., Jin, Y., Su, Z., . . . Shakeri-Nejad, K. (2019). Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects. Clinical pharmacokinetics, 58(3), 349-361. https://doi.org/10.1007/s40262-018-0700-3
Chicago Style (17th ed.) CitationGardin, Anne, Mike Ufer, Eric Legangneux, Gianluca Rossato, Yi Jin, Zhenzhong Su, Parasar Pal, Wenkui Li, and Kasra Shakeri-Nejad. "Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects." Clinical Pharmacokinetics 58, no. 3 (2019): 349-361. https://doi.org/10.1007/s40262-018-0700-3.
MLA (9th ed.) CitationGardin, Anne, et al. "Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects." Clinical Pharmacokinetics, vol. 58, no. 3, 2019, pp. 349-361, https://doi.org/10.1007/s40262-018-0700-3.